Search

Search Constraints

You searched for: Author/Creator Zhang, Birong

Search Results

2. Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927. Issue 16 (15th August 2019)

3. Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer. (15th October 2021)

4. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. Issue 13 (1st July 2017)

6. Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model. Issue 18 (15th September 2017)

7. Lead optimization of a pyrazolo[1, 5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies. Issue 16 (15th August 2016)

8. Metabolic regulation by prostaglandin E2 impairs lung group 2 innate lymphoid cell responses. Issue 3 (14th October 2022)

9. Steric and Electronic Factors Influence Regio‐isomeric Thiazole Formations Between Substituted Benzothioamides and Ethyl Bromopyruvate. (9th December 2013)

10. Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha. Issue 7 (1st April 2019)